Articles related to SKIN CONDITIONS/RASH

Melasma is a complex condition with dermatological and psychological implications; early recognition and preventive measures can significantly impact patient outcomes. Learn more about the role primary care physicians can play in managing this challenging condition.

The recent FDA approval of cantharidin introduces a novel topical treatment for molluscum contagiosum in patients aged 2 and above, presenting a significant stride in dermatological solutions.

A 77-year-old man with a history of solar keratoses presents a progressively enlarging and darkening lesion on his right cheek, as observed by his wife over a year, with a dermoscopic examination revealing asymmetric pigmented follicular openings and greyish globules and dots.

On July 11, 2023, participate in the AMCP PIE Webinar to learn more about the potential of VP-102, an investigational medication for molluscum contagiosum that is now undergoing FDA assessment.

Grappling with the diagnostic challenges of Prurigo nodularis requires not only a comprehensive patient evaluation but also a deeper understanding of the disease’s complex pathophysiology and associated comorbidities. Clinicians can leverage this knowledge to devise effective, individualized treatment strategies.

A 37-year-old man presented with persistent swelling, limited range of motion, and loss of hand dexterity in both hands. He had a history of IV drug use, including opiates and methamphetamine. The examination showed diffuse swelling without joint inflammation. Lab tests were normal, and imaging revealed soft-tissue swelling. The diagnosis was puffy hand syndrome, a common complication of IV drug use. Treatment options are mainly symptomatic, including discontinuation of IV drug use and the use of low-stretch bandages and compression gloves. Puffy hand syndrome, often unrecognized by general practitioners, should be considered in patients with swelling and limited hand function who have a history of IV drug use. The syndrome involves progressive fibrosis of subcutaneous tissues due to repeated injection-induced vascular and dermal sclerosis. Diagnosis is based on clinical presentation, history, and evaluation ruling out other conditions. Treatment focuses on symptomatic relief and cessation of IV drug use.